SCHEMBL19377435

SCHEMBL19377435

CCN1Cc2ccc(CS(=O)(=O)c3ccc(NC(=O)NC(C)c4ccccc4)cc3)cc2C1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.46
▸ KMT2A Q03164 2/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ NAMPT P43490 4/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ IDH1 O75874 1/20 0.42
▸ GFER P55789 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ MTOR P42345 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ RORC P51449 2/20 0.40
▸ EPHX2 P34913 2/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ ACACB O00763 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ C5 P01031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377410 0.92 HSD17B10 (0.46) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377183 0.91 HSD17B10 (0.48) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377317 0.91 HSD17B10 (0.48) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377210 0.91 HSD17B10 (0.48) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377402 0.90 KMT2A (0.45) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377477 0.90 HSD17B10 (0.43) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377513 0.89 HSD17B10 (0.43) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377191 0.86 ROCK2 (0.53) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377193 0.86 ROCK2 (0.53) HSD17B10KMT2AALDH1A1NAMPTCYP2C9
SCHEMBL19377006 0.85 HSD17B10 (0.43) HSD17B10KMT2AALDH1A1NAMPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR HSD17B10 2852/4885KMT2A 3175/4885ALDH1A1 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback